NCT07145346View on ClinicalTrials.gov

Suzetrigine for Acute Pain Control in Patients With Multiple Rib Fractures

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Rib Fractures
Interventions
DRUG

Suzetrigine (SUZ)

The intervention arm will receive oral suzetrigine (100 mg loading dose followed by 50 mg every 12 hours).

DRUG

Placebo

The control arm will receive placebo capsules matched to suzetrigine for oral administration.

Trial Locations (1)

92868

University of California, Irvine, Orange

All Listed Sponsors
lead

University of California, Irvine

OTHER